Literature DB >> 9101704

Negative entropy of halothane binding to protein: 19F-NMR with a novel cell.

T Yoshida1, M Tanaka, Y Mori, I Ueda.   

Abstract

An obvious difficulty of the study of binding of volatile anesthetics to proteins is to prevent loss of the ligand during the procedure. A novel NMR tube was designed that consists of concentric double cylinders which slide each other under sealed condition. A gas space is left in the tube to measure the free anesthetic concentration in the gas phase, which is in equilibrium with the solution. The enthalpy change of anesthetic transfer from water to BSA, deltaH(w-->r) was -40 kJ x mol(-1). The Gibbs free energy deltaG(w-->r) was -14.0 kJ x mol(-1) at 283 K (K(D) = 2.6 mM) and increased to -11.6 kJ x mol(-1) at 310 K (K(D) = 10.9 mM). The maximum binding site (Bmax) was 19.3 at 10 degrees C and increased to 34.5 at 37 degrees C. The entropy change, deltaS(w-->r) was -92 J x mol(-1) x K(-1) and was almost constant in the temperature range 10 approximately 37 degrees C. Contrary to the general consensus that hydrophobic interaction is entropy-driven, the binding of halothane to BSA was enthalpy-driven, compensating the opposing effect of deltaS with negative deltaH at the biologically meaningful temperature range. Possible cause of the negative deltaS relating to the conformational change of BSA is discussed.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9101704     DOI: 10.1016/s0304-4165(97)00014-7

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  2 in total

1.  Does pressure antagonize anesthesia? Opposite effects on specific and nonspecific inhibitors of firefly luciferase.

Authors:  I Ueda; H Matsuki; H Kamaya; P R Krishna
Journal:  Biophys J       Date:  1999-01       Impact factor: 4.033

2.  Is there a specific receptor for anesthetics? Contrary effects of alcohols and fatty acids on phase transition and bioluminescence of firefly luciferase.

Authors:  I Ueda; A Suzuki
Journal:  Biophys J       Date:  1998-08       Impact factor: 4.033

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.